According to the Economic Daily, under the influence of various unfavorable factors, the US epidemic prevention and control work is still struggling. Recently, many pharmaceutical companies in Europe and the United States have made important progress in researching new crown vaccines. However, the situation in the United States is far from optimistic. As the hardest hit by the global epidemic, …